demonstrated the induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist (73), highlighting the importance of TLR7 agonists in enhancing antitumor immunity against breast cancer. Here, TLR7 is linked to breast carcinoma.